Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT02642939 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDIV

Sponsor class

Stopped Lack of enrollment

Conditions

Non-Small Cell Lung Cancer (NSCLC)

Interventions

DRUG: Mifepristone

Sponsor

Check, Jerome H., M.D., Ph.D.

Collaborators

[object Object]